• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.

作者信息

Johnson B J, Peacock V, Schneider J S

机构信息

Department of Neurology, Hahnemann University, Philadelphia, PA 19102, USA.

出版信息

Pharmacol Biochem Behav. 1995 Aug;51(4):617-22. doi: 10.1016/0091-3057(94)00424-h.

DOI:10.1016/0091-3057(94)00424-h
PMID:7675833
Abstract

Dihydrexidine (trans-10,11-dihydroxy5,6,6a,7,8,12b hexanhyydrobenso- [alpha]phenanthridine) is a full dopamine D1 agonist. In rhesus macaque monkeys rendered hemiparkinsonian by unilateral intracarotid infusions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), dihydrexidine (0.15-0.9 mg/kg) elicited dose-dependent contralateral rotation. The effects of dihydrexidine were blocked by pretreatment with the D1 antagonist SCH 23390 (0.03 mg/kg), but not by the D2 antagonist raclopride (0.025 mg/kg). These results suggest a functional role for D1 receptors in stimulating motor behavior in a primate model of Parkinson's disease.

摘要

相似文献

1
Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
Pharmacol Biochem Behav. 1995 Aug;51(4):617-22. doi: 10.1016/0091-3057(94)00424-h.
2
Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
Brain Res. 1994 Nov 7;663(1):140-4. doi: 10.1016/0006-8993(94)90471-5.
3
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.多巴胺 D1 激动剂 SKF 81297 与多巴胺 D2 激动剂 LY 171555 协同作用,刺激 1-甲基-4-苯基-1,2,3,6-四氢吡啶损伤的帕金森病恒河猴的运动行为。
Mov Disord. 1994 Nov;9(6):664-72. doi: 10.1002/mds.870090613.
4
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.对先前停用氟哌啶醇治疗的卷尾猴长期给予 D1 受体拮抗剂 SCH 23390 和 D2 受体拮抗剂雷氯必利治疗。锥体外系综合征和多巴胺能超敏反应。
Psychopharmacology (Berl). 1993;112(2-3):389-97. doi: 10.1007/BF02244938.
5
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.对先前接触过多巴胺拮抗剂的猴子长期给予低剂量D1拮抗剂NNC 756和D2拮抗剂雷氯必利进行治疗。
Psychopharmacology (Berl). 1994 Apr;114(3):495-504. doi: 10.1007/BF02249341.
6
Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.大鼠腹侧海马多巴胺D1和D2系统与空间工作记忆
Neuroscience. 1999 Mar;89(3):743-9. doi: 10.1016/s0306-4522(98)00346-7.
7
Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.“MPTP”猴中多巴胺D1和D2受体之间的功能相互作用
Eur J Pharmacol. 1994 Mar 3;253(3):215-24. doi: 10.1016/0014-2999(94)90194-5.
8
Effect of D1 receptor stimulation in normal and MPTP monkeys.D1受体刺激对正常和MPTP处理的猴子的影响。
Neurosci Lett. 1989 Sep 25;104(1-2):223-8. doi: 10.1016/0304-3940(89)90358-3.
9
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.经预处理、单侧注射MPTP处理的猴子作为帕金森病模型的有效性:对D2激动剂喹吡罗和D1激动剂SKF 81297的治疗作用和不良作用的详细行为分析。
Behav Pharmacol. 1999 Mar;10(2):163-73. doi: 10.1097/00008877-199903000-00005.
10
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
Eur J Pharmacol. 1993 Apr 22;235(1):143-7. doi: 10.1016/0014-2999(93)90834-5.

引用本文的文献

1
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease.Tavapadon,一种用于治疗帕金森病的 D1/D5-选择性部分多巴胺激动剂的研发背景。
CNS Neurol Disord Drug Targets. 2024;23(4):476-487. doi: 10.2174/1871527322666230331121028.
2
Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.比较 D₁ 多巴胺完全激动剂二氢麦角隐亭和 doxanthrine 在帕金森病 6-OHDA 大鼠模型中的作用。
Psychopharmacology (Berl). 2012 Jul;222(1):81-7. doi: 10.1007/s00213-011-2625-5. Epub 2012 Jan 6.
3
Dihydrexidine--the first full dopamine D1 receptor agonist.
二氢麦角隐亭——首个完全多巴胺D1受体激动剂。
CNS Drug Rev. 2004 Fall;10(3):230-42. doi: 10.1111/j.1527-3458.2004.tb00024.x.